Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors

Psychopharmacology

Volumn 123, Issue 4, 1996, Pages 303-306

  Self, David W ^a,b   Belluzzi, James D ^a   Kossuth, Sara ^a   Stein, Larry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; D1 agonists; D1 antagonists; D2 antagonists; Dopamine; Raclopride; Reinforcement; SCH 23390; Self administration; SKF 82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RACLOPRIDE; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SALICYLAMIDE DERIVATIVE; SK&F 82958;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BENZAZEPINES; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); SALICYLAMIDES; SELF ADMINISTRATION;

EID: 0029662290     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246638     Document Type: Article

References (28)

1. 1 receptor efficacy. Eur J Pharmacol 188: 335-347
2. 2 agonists. Soc Neurosci Abstr 19: 1862
3. 2 receptors in maintaining cocaine self-administration. Pharmacol Biochem Behav 39: 911-915
4. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816
5. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209-218
6. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals. In: Sahgal A (ed) Behavioural neuroscience, vol. ii, a practical approach. Oxford University Press, Oxford, pp 117-143
7. 4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci 89: 12093-12097
8. Davis MW, Smith SG (1977) Catecholaminergic mechanisms of reinforcement: direct assessment by drug self-administration. Life Sci 20: 483-492
9. DeWit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with noradrenergic blockers phentolamine and phenoxybenzamine. Can J Psychol 31: 195-203
10. 2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105: 151-156
11. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93-96
12. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242: 715-723
13. Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarendon, Oxford, pp 214-263
14. 1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315-320
15. 2 interaction. Eur J Pharmacol 160: 377-384
16. 3 dopamine receptors. J Neurosci 14: 1463-1476
17. Risner ME, Jones BE (1980) Intravenous self-administration of cocaine and norcaine by dogs. Psychopharmacology 71: 83-89
18. Roberts DCS, Vickers G (1984) Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioral screen for antipsychotic activity. Psychopharmacology 82: 135-139
19. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6: 616-620
20. Self DW, Stein L (1992a) Receptor subtypes in opioid and stimulant reward. Pharmacol Toxicol 70: 87-94
21. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582: 349-352
22. Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13: 61-69
23. 1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology 113: 51-52
24. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40: 191-225
25. Wise RA, Murray A, Bozarth MA (1990) Bromocriptinc self-administration and bromocriptine reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355-360
26. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24: 531-535
27. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230: 678-683
28. Yokel RA, Wise RA (1978) Amphetamine-type reinforcement by dopaminergic agonists in the rat. Psychopharmacology 58: 289-296